Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

Registered drugNo placebo

Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Abemaciclib
Sponsor:Champalimaud Clinical Centre

Contact Research Centre

Hydrocele+1

Recruiting

Study on Sclerotherapy for Hydrocele and Spermatocele Using Lauromacrogol 400 and Ethanol in Adult Patients

Registered drugNo placebo

Study on Sclerotherapy for Hydrocele and Spermatocele Using Lauromacrogol 400 and Ethanol in Adult Patients

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Ethanol, Anhydrous
Sponsor:Region Jamtland Harjedalen

Contact Research Centre

Substances studied in this area

The therapies tested most often in Reproductive system and breast disorders trials.

Paclitaxel118 clinical trials Carboplatin86 clinical trials Pembrolizumab77 clinical trials Letrozole73 clinical trials Fulvestrant58 clinical trials Docetaxel49 clinical trials Enzalutamide49 clinical trials Exemestane46 clinical trials Anastrozole44 clinical trials

Reproductive system and breast disorders – page 20

Conditions in this area

Clinical trials in Reproductive system and breast disorders

956 clinical trials

Endometrial sarcoma

Study on Stopping or Continuing Anastrozole, Letrozole, and Exemestane for Patients with Advanced or Metastatic Low-Grade Endometrial Stromal Sarcoma

Erectile dysfunction

Study of Botulinum Toxin and Saline Solution for Erectile Dysfunction in Patients Unresponsive to Standard Treatments

Paget's disease of the vulva

Study on the Use of Methyl Aminolevulinate and PAGETEX Device for Treating Vulvar Extra-Mammary Paget's Disease in Women

Infertility female

Study on Infertility Treatment with Follitropin Alfa and Lutropin Alfa for Women Over 35 with Low Ovarian Response

Ovarian epithelial cancer

Study on Hyperthermic Intraperitoneal Chemotherapy with Cisplatin for Patients with Recurrent Ovarian Cancer

Breast cancer

Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Ovarian cancer

Study of Pembrolizumab with Etoposide and Cisplatin for First-Line Treatment in Patients with Small Cell Ovarian Cancer

Hormone receptor positive HER2 negative breast cancer

Study on Alisertib with Hormone Therapy for Patients with HR+, HER2- Recurrent or Metastatic Breast Cancer

Oesophageal carcinoma+3

Study on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer

HER2 negative breast cancer

Study of Pembrolizumab with Chemotherapy for Patients with HER2-Negative Inflammatory Breast Cancer

Breast cancer+4

Study on zAvatar Test for Treatment Decisions in Relapsed Ovarian Cancer and Metastatic Breast Cancer Using Palbociclib and Drug Combination for Eligible Patients

Hydrocele+1

Study on Sclerotherapy for Hydrocele and Spermatocele Using Lauromacrogol 400 and Ethanol in Adult Patients

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.